University of Alberta - Pharmaceuticals & Healthcare - Deals and Alliances Profile
September 2018
44
About the Report
About the Report
Summary
University of Alberta (UALBERTA) is an educational university that provides undergraduate, international, graduate, continuing studies and open studies programs. The university offers educational programs in agricultural food and nutritional science, English and film studies, history and classics, forest science and management, human ecology, art and design, drama, resource economics and environmental sociology, chemicals and material engineering, economics, interdisciplinary studies, psychology, sociology, women's studies, modern languages and cultural studies, music, and others. It offers translational and discovery driven research across various areas of impact in science, social sciences, humanities and fine arts. UALBERTA is headquartered in Edmonton, Alberta, Canada.
University of Alberta-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
University of Alberta, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
University of Alberta, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Alberta, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
University of Alberta, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Alberta, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
University of Alberta, Medical Devices Deals, 2012 to YTD 2018 10
University of Alberta, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
University of Alberta, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Corline Biomedical to Enter into Agreement with University of Alberta 12
Licensing Agreements 13
Ceapro Expands Licensing Agreement with University of Alberta 13
Asset Transactions 14
NovaDigm Therapeutics Acquires Rights to Beta-Mannan Trisaccharide Conjugate from University of Alberta, Louisiana State University School of Medicine and University of Toronto 14
ProtoKinetix Acquires Certain Patents from University of Alberta 15
University of Alberta-Key Competitors 16
University of Alberta-Key Employees 17
University of Alberta-Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Joint Venture 19
Recent Developments 20
Government and Public Interest 20
Jul 25, 2018: Scientists identify biomarkers to predict and help prevent stillbirth 20
Jul 10, 2018: Researchers identify new compounds to treat RSV, Zika virus 21
Jun 14, 2018: U of A researchers identify possible new pathway to treat anxiety 22
Mar 14, 2018: Grants Awarded to 13 Canadian Initiatives to Help Advance the Goal of Eliminating Chronic Hepatitis C Infection in High-Risk Populations 24
Mar 08, 2018: Canadian researchers open a new front in the fight against MS 26
Feb 19, 2018: Government of Canada and Brain Canada announce a USD 10-million grant to establish a platform that will help researchers share data more widely and efficiently 27
Feb 07, 2018: USD 5-million gift positions Alberta to become international leader in youth mental heal 28
Jan 25, 2018: UAlberta health research gets strong dose of funding 30
Oct 11, 2017: Uncovering origins of developmental brain disorders could eventually help treat seizures 34
Sep 01, 2017: New technology could reduce costs significantly in protein analysis during drug development 35
Mar 23, 2017: Possible new target for treatment of multiple sclerosis found by U of A researchers 36
Product News 37
May 29, 2018: Ceapro Confirms Excellent Bioavailability of its New Water Soluble Chemical Complex Coenzyme Q10-Beta Glucan 37
Apr 17, 2018: New approach enhances gene-editing accuracy 39
Jan 19, 2018: Synthetic horsepox virus raises hopes for improved smallpox and cancer treatments 40
Other Significant Developments 41
Oct 17, 2017: Scientific Update for Diabetes, Kidney Ischemia, Liver Perfusion, Retinal Cell Replacement, Monoclonal Antibody Production and Immune Cell Cryopreservation Recovery 41
Jul 21, 2017: IBM and University of Alberta Publish New Data on Machine Learning Algorithms to Help Predict Schizophrenia 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44
List of Figure
List of Figures
University of Alberta, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of Alberta, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of Alberta, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of Alberta, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of Alberta, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Alberta, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
University of Alberta, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Alberta, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
University of Alberta, Medical Devices Deals, 2012 to YTD 2018 10
List of Table
List of Tables
University of Alberta, Pharmaceuticals & Healthcare, Key Facts 2
University of Alberta, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Alberta, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
University of Alberta, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Alberta, Deals By Therapy Area, 2012 to YTD 2018 9
University of Alberta, Medical Devices Deals, 2012 to YTD 2018 10
University of Alberta, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Corline Biomedical to Enter into Agreement with University of Alberta 12
Ceapro Expands Licensing Agreement with University of Alberta 13
NovaDigm Therapeutics Acquires Rights to Beta-Mannan Trisaccharide Conjugate from University of Alberta, Louisiana State University School of Medicine and University of Toronto 14
ProtoKinetix Acquires Certain Patents from University of Alberta 15
University of Alberta, Key Competitors 16
University of Alberta, Key Employees 17
University of Alberta, Other Locations 18
University of Alberta, Subsidiaries 18
University of Alberta, Joint Venture 19
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.